7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolact

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

26023957, A61K 3158

Patent

active

045593310

ABSTRACT:
Novel 7.alpha.-substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolactones of the formula ##STR1## wherein ##STR2## is a CC single or CC double bond or the group ##STR3## R.sup.7 is the group SR', R' being a hydrogen atom or a straight-chain or branched alkyl residue of 1-6 carbon atoms optionally substituted by a hydroxy or acyloxy group, the group COOR" or the group COR" wherein R" is an alkyl group of 1-4 carbon atoms and ##STR4## is a CC single bond or the group ##STR5## have antialdosterone activity with reduced endocrinological side effects.

REFERENCES:
patent: 4129564 (1978-12-01), Wiechert et al.
patent: 4291029 (1981-09-01), Wiechert et al.
patent: 4450107 (1984-05-01), Nickisch et al.
patent: 4450170 (1984-05-01), Beeley et al.
patent: 4500522 (1985-02-01), Nickisch et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolact does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolact, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolact will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2175110

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.